6505--762-25-1-040-0284 -Tucson CMOP FEXOFENADINE -(VA-25-00020806)
ID: 36C77025Q0093Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/7d4d3d6f496b46c5a18f88cc616cbb8e/view
Timeline
  1. 1
    Posted Jan 3, 2025, 12:00 AM UTC
  2. 2
    Updated Jan 3, 2025, 12:00 AM UTC
  3. 3
    Due Jan 10, 2025, 9:00 PM UTC
Description

The Department of Veterans Affairs is soliciting proposals for the procurement of Fexofenadine HCL 60MG (500CT) for the Tucson Consolidated Mail Outpatient Pharmacy (CMOP). Vendors are required to submit detailed quotes that include a signed SF1449 solicitation cover page, a completed pricing schedule, a valid wholesale distributor license, and OEM authorization for over-the-counter products, ensuring compliance with the Buy American Act and other regulatory standards. This pharmaceutical product is critical for treating allergies and must meet stringent quality and safety requirements, including a minimum shelf life of one year upon delivery. Proposals are due by January 10, 2025, at 3:00 PM CT, and interested vendors can contact Contract Specialist Jennifer D Coleman at jennifer.coleman4@va.gov for further information.

Point(s) of Contact
Jennifer D ColemanContract Specialist
jennifer.coleman4@va.gov
Files
Title
Posted
36C77025Q0093_1.docx
Jan 3, 2025, 7:05 PM UTC
The Department of Veterans Affairs (VA), through Network Contracting Office 15, is seeking bids for the procurement of Fexofenadine HCl 60mg medication to be delivered to the Tucson Consolidated Mail Outpatient Pharmacy (CMOP). The solicitation number is 36C77025Q0093, with a response deadline set for January 10, 2025, at 3 PM Central Time. The contract is categorized as a Small Business Set-Aside, and offers are to be submitted via email to the designated Contract Specialist, Jennifer Coleman. Interested vendors must comply with the Drug Supply Chain Security Act (DSCSA), submitting their state wholesale distributor license along with their quotes. Submissions should include a signed solicitation cover page, a price schedule in Excel format, and a Buy American Act (BAA) certificate indicating the country of origin for the products. The estimated issue date for the solicitation is January 3, 2025, and delivery is expected within ten days after receipt of the order. This presolicitation notice invites responsible sources to participate in meeting the ongoing pharmaceutical needs of veterans.
36C77025Q0093.docx
Jan 3, 2025, 8:05 PM UTC
The document pertains to a solicitation issued by the Department of Veterans Affairs for a pharmaceutical supply contract, specifically for the Tucson Consolidated Mail Outpatient Pharmacy (CMOP). The requisition outlines a detailed request for offers (RFP), specifying requirements, pricing schedules, delivery protocols, and compliance clauses. The contract emphasizes the importance of providing pharmaceuticals that meet strict regulatory and quality standards, including barcoding and therapeutic equivalence. Offerors are instructed to submit detailed quotes, including pricing in Excel format and relevant legal documentation. Delivery logistics are crucial, mandating coordination with CMOP to adhere to operational hours and tracking procedures. The document incorporates various Federal Acquisition Regulation (FAR) clauses, underlining contractual obligations and compliance requirements for contractors serving federal entities. The content highlights the government's focus on efficient procurement processes, aiming to supply high-quality pharmaceuticals while ensuring adherence to legal and safety standards during the acquisition process.
S02 - Pricing Schedule Q0093 - FEXOFENADINE.xlsx
Jan 3, 2025, 8:05 PM UTC
The document outlines a Request for Quote (RFQ) from the CMOP Tucson facility, identified as RFQ 36C77025Q0093, for a specific pharmaceutical product, Fexofenadine HCL 60MG (500CT). Vendors must submit their proposals by January 10, 2025, at 3:00 PM CT, including a signed SF1449 solicitation cover page, a completed quote spreadsheet, a valid wholesale distributor license, and OEM authorization for OTC products. Additionally, a Buy American Act certificate is required. All submitted quotes must adhere to stipulations regarding expiration dates, ensuring that products have a minimum shelf life of one year upon delivery. Vendors are allowed to propose one quote only and must provide details in the comments section regarding any variations in quantities or expiration dates. The document emphasizes compliance with regulatory requirements and the procurement process for pharmaceuticals, reflecting the government's commitment to maintaining standards in sourcing medical supplies.
Lifecycle
Title
Type
6505--762-25-1-040-0284 -Tucson CMOP FEXOFENADINE -(VA-25-00020806)
Presolicitation
6505--762-25-1-040-0284 -Tucson CMOP FEXOFENADINE -(VA-25-00020806)
Currently viewing
Solicitation
Similar Opportunities
6505--Emtricitabine/Tenofovir Disoproxil Fumarate Tablets
Buyer not available
The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Emtricitabine 200mg/Tenofovir Disoproxil Fumarate 300mg Tablets, which will serve various federal health entities including the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract aims to ensure an uninterrupted supply of this essential medication for a period of one year, with options for four additional one-year terms, emphasizing the VA's commitment to maintaining critical pharmaceutical supplies. The estimated annual requirement is approximately 91,583 bottles, and interested offerors must ensure their product has a unique National Drug Code (NDC) and complies with specific packaging requirements, including safety caps. The solicitation is expected to be issued electronically on or around April 26, 2025, with a response deadline of May 13, 2025; inquiries can be directed to Deb Fassl at Deborah.Fassl@va.gov.
6505--Ranolazine Sustained Action (SA) Tablets
Buyer not available
The Department of Veterans Affairs is soliciting proposals for the supply of Ranolazine Sustained Action Tablets, a pharmaceutical product essential for veteran healthcare. Bidders are required to submit pricing for a base year and four option years, along with compliance documentation including National Drug Code (NDC) numbers and adherence to packaging specifications as mandated by the Drug Supply Chain Security Act. This procurement underscores the government's commitment to ensuring a reliable supply of quality medications while adhering to federal standards, including Good Manufacturing Practices (cGMP). Interested parties should contact Contract Specialist Deborah S. Fassl at Deborah.Fassl@va.gov for further details regarding submission requirements and deadlines.
6505--Buspirone RFP
Buyer not available
The Department of Veterans Affairs is soliciting proposals for the supply of Buspirone HCL, a pharmaceutical product essential for the healthcare services provided to veterans. The procurement process requires vendors to submit pricing for multiple line items covering a base year and four option years, ensuring compliance with the Drug Supply Chain Security Act and FDA Good Manufacturing Practices. This contract aims to maintain a reliable supply chain for federal healthcare providers, including the VA, Department of Defense, and Indian Health Service, while securing volume-based pricing for the necessary pharmaceuticals. Interested vendors must submit their offers by May 8, 2025, at 2:30 PM CT, and can direct inquiries to Contract Specialist Amber Zavala at amber.zavala@va.gov.
6505--Perphenazine Tablets (VA-25-00037353)
Buyer not available
The Department of Veterans Affairs is soliciting proposals for the procurement of Perphenazine tablets under solicitation number VA-25-00037353. This contract aims to ensure a reliable supply of this pharmaceutical product for both the Department of Veterans Affairs and the Department of Defense, with a focus on service-disabled veteran-owned, women-owned, and HUBZone small businesses. The procurement process will adhere to the Drug Supply Chain Security Act and require compliance with FDA regulations, including Good Manufacturing Practices. Interested offerors must submit their proposals by May 1, 2025, at 2:30 PM CDT, and can direct inquiries to Contract Specialist Anthony DiCrescenzo at Anthony.DiCrescenzo@va.gov.
6505--760-25-1-050-0237 -Leavenworth CMOP OM PHARMACEUTICALS -(VA-25-00028391)
Buyer not available
The Department of Veterans Affairs (VA) is preparing to issue a request for proposal (RFP) for the procurement of fourteen specified pharmaceuticals to be delivered to the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) facility in Kansas. This opportunity is exclusively set aside for small businesses under the product service code 6505, which pertains to drugs and biologicals, and requires interested vendors to submit a price schedule, a signed SF1449 cover page, valid state wholesale distributor licenses, and a Buy American Act certificate. The procurement is crucial for ensuring that veterans receive timely access to necessary pharmaceuticals, with the estimated RFP issue date set for March 6, 2025, and a response deadline of March 17, 2025. Interested parties should direct their submissions and inquiries to Contracting Officer Kelley Cunningham at kelley.cunningham@va.gov or by phone at 913-684-0140.
Fexofenadine HCL Follow On MOD P00002
Buyer not available
Special Notice: DEPT OF DEFENSE - DEFENSE LOGISTICS AGENCY is seeking Fexofenadine HCL Follow On MOD P00001. Fexofenadine HCL is a drug used to relieve symptoms of seasonal allergies such as runny nose, sneezing, itchy or watery eyes, and itching of the nose or throat. This procurement is for NDC changes. For more information, please contact Catherine Gilbert at catherine.gilbert@dla.mil or 2157374778.
6505--Carvedilol Tablets (VA-25-00048048)
Buyer not available
The Department of Veterans Affairs is soliciting proposals for the supply of Carvedilol Tablets under solicitation number 36E79725R0028, with an amendment extending the submission deadline to May 1, 2025, at 2:30 PM Central Daylight Time. Offerors are required to provide pricing for various types of Carvedilol Tablets, submit unique National Drug Code (NDC) numbers, and comply with federal regulations, including the Drug Supply Chain Security Act (DSCSA) and FDA manufacturing standards. This procurement is crucial for ensuring a reliable supply of pharmaceuticals to enhance healthcare services for veterans and active duty military personnel. Interested contractors should direct their proposals to the specified VA email addresses and acknowledge receipt of the amendment to remain eligible for consideration.
770 - CLINDAMYCIN P04 1% TOP SWAB (770-25-3-801-0368)
Buyer not available
The Department of Veterans Affairs is soliciting proposals for the procurement of Clindamycin PO4 1% Top Swabs, specifically for use in its Consolidated Mail Outpatient Pharmacy (CMOP) facilities. Vendors are required to submit a detailed pricing schedule, confirm compliance with safety and labeling standards, and adhere to strict delivery protocols, including providing necessary documentation such as state licenses and bar code compliance. This procurement is crucial for ensuring the availability of quality pharmaceutical supplies for veterans, reflecting the VA's commitment to regulatory compliance and operational efficiency. Interested vendors must submit their proposals by April 30, 2025, and can contact Jennifer L. Knight at jennifer.knight@va.gov or 913-684-0162 for further information.
6505--Topiramate Tablets (VA-25-00047941)
Buyer not available
The Department of Veterans Affairs (VA) is soliciting proposals for the supply of Topiramate Tablets under the contract number VA-25-00047941. This procurement aims to ensure a consistent supply of essential pharmaceuticals, including Topiramate and Tadalafil, to support various government healthcare programs, including the Department of Defense and the Indian Health Service. Offerors are required to comply with the Drug Supply Chain Security Act (DSCSA), including specific packaging, labeling standards, and rigorous cGMP compliance, while submitting pricing for the base year and four option years. Interested parties should contact Contract Specialist Billy Fong at Billy.Fong@va.gov for further details and to participate in the proposal submission process.
760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
Buyer not available
The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.